Investigating the role of orexin in stress-induced binge eating in female mice

M.J. O'Shea1, M. Muthmainah2, R. Goncalves Anversa3,4, L.C. Walker3,4, A. Gogos3,4, M.H. James5,6, P. Sumithran7,8, R.M. Brown1,3
1University of Melbourne, Department of Biochemistry and Pharmacology, Melbourne, Australia, 2Universitas Sebelas Maret, Department of Anatomy, Surakarta, Indonesia, 3Florey Institute of Neuroscience and Mental Health, Mental Health Division, Melbourne, Australia, 4University of Melbourne, The Florey Department of Neuroscience and Mental Health, Melbourne, Australia, 5Rutgers University, Department of Psychiatry and Rutgers Addiction Research Center, Piscataway, United States, 6University of Sydney, Brain and Mind Center and School of Psychology, Sydney, Australia, 7Monash University, Department of Surgery, Melbourne, Australia, 8Alfred Health, Department of Endocrinology and Diabetes, Melbourne, Australia

Background: Binge eating is a core feature of both bulimia nervosa and binge eating disorder, which impacts approximately 4-5% of adults, globally. Stress has been identified as a major antecedent to binge eating episodes, particularly in women. However, further research is needed to identify the neurobiological mechanisms driving female, stress-induced binge eating and thus develop effective pharmacological treatments. The orexin neuropeptide system is known to play a critical role in both stress and feeding-related behaviours, hence represents a promising candidate for further research.
Aims & Objectives: We aimed to investigate the role of orexin in female stress-induced binge eating using a mouse model. We hypothesised that orexin neurons would be recruited as a result of this behaviour, and that administration of an orexin-1 receptor antagonist (SB-334867) would reduce stress-induced binge eating.
Method: Our model comprised of repeated cycles of exposure to a mild stressor and intermittent access to palatable food to induce binge-like eating in female mice. Animals were administered either SB-334867 (15 mg/kg, s.c.) or vehicle (5% DMSO in saline) prior to stress binge testing. Immunohistochemistry was performed to assess both orexin levels in the lateral hypothalamus and Fos expression throughout the brain (Fos is a marker of neuronal activity).
Results: Immunohistochemistry revealed activation of lateral hypothalamic orexin neurons in stress binge mice compared to controls and a specific recruitment of orexin immunoreactive cells. Further, systemic antagonism of the orexin-1 receptor with SB-334867 reduced stress-induced binge eating. This effect was associated with reduced activation of the nucleus accumbens core, and increased activation of the bed nucleus of the stria terminalis (BNST) compared to vehicle-treated mice.
Discussion & Conclusions: Our data implicates orexin signaling through the orexin-1 receptor in stress-induced binge eating, likely via a network involving components of the limbic system (nucleus accumbens core and BNST). Further, our results indicate that repeated cycles of stress-induced binge eating recruit the orexin system (i.e. evidencing engagement of the orexin ‘reserve’). Hence, the orexin system may represent an exciting target for pharmacotherapeutic development.
In sessions